Ledger.Open graph →
SEC Form D · filed October 16, 2023

SAB Biotherapeutics, Inc

Offering
$7.5M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Sioux Falls, SD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Erick C. Lucera · Sioux Falls, SDDirectorDavid C. Link · Sioux Falls, SDDirectorEddie J. Sullivan · Sioux Falls, SDExec · DirectorWilliam C. Polvino · Sioux Falls, SDDirectorChristine J. Hamilton · Sioux Falls, SDDirectorScott J. Giberson · Sioux Falls, SDDirectorAndrew G. Moin · Sioux Falls, SDDirectorJeffrey G. Spragens · Sioux Falls, SDDirectorRussell J. Beyer · Sioux Falls, SDExecSamuel J. Reich · Miami, FLExec · DirectorRussell J. Beyer · Sioux Falls, SDExecErick C. Lucera · Sioux Falls, SDDirectorDavid C. Link · Sioux Falls, SDDirectorSamuel J. Reich · Miami, FLExec · DirectorEddie J. Sullivan · Sioux Falls, SDExec · DirectorWilliam C. Polvino · Sioux Falls, SDDirectorChristine J. Hamilton · Sioux Falls, SDDirectorScott J. Giberson · Sioux Falls, SDDirectorAndrew G. Moin · Sioux Falls, SDDirectorJeffrey G. Spragens · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗